Yuditiya Purwosunu1, Widyastuti Sarkoen, Sabaratnam Arulkumaran, Jan Segnitz. 1. Department of Obstetrics and Gynecology, University of Indonesia, Jakarta, Indonesia; St. George's Medical School, London, England; and the Fogarty Institute for Innovation, San Luis Obispo, California.
Abstract
BACKGROUND: Postpartum hemorrhage is the leading cause of maternal mortality worldwide. Vacuum-induced uterine tamponade is a possible alternative approach to balloon tamponade systems for the treatment of postpartum hemorrhage resulting from atony. METHOD: In a prospective proof-of-concept investigation of 10 women with vaginal deliveries in a hospital setting who failed first-line therapies for postpartum hemorrhage, tamponade was used. Vacuum-induced uterine tamponade was created through a device inserted transvaginally into the uterine cavity. An occlusion balloon built into the device shaft was inflated at the level of the external cervical os to create a uterine seal. Negative pressure was created by attaching a self-contained, mobile, electrically powered, pressure-regulated vacuum pump with a sterile graduated canister. EXPERIENCE: In all 10 cases, the suction created an immediate seal at the cervical os, 50-250 mL of residual blood was evacuated from the uterine cavity, the uterus collapsed and regained tone within minutes, and hemorrhaging was controlled. The device remained in place for a minimum of 1 hour and up to 6.5 hours in one case while vaginal and perineal lacerations were easily repaired. CONCLUSION: This preliminary investigation suggests that a device designed to create vacuum-induced uterine tamponade may be a reasonable alternative to other devices used to treat atonic postpartum hemorrhage.
BACKGROUND: Postpartum hemorrhage is the leading cause of maternal mortality worldwide. Vacuum-induced uterine tamponade is a possible alternative approach to balloon tamponade systems for the treatment of postpartum hemorrhage resulting from atony. METHOD: In a prospective proof-of-concept investigation of 10 women with vaginal deliveries in a hospital setting who failed first-line therapies for postpartum hemorrhage, tamponade was used. Vacuum-induced uterine tamponade was created through a device inserted transvaginally into the uterine cavity. An occlusion balloon built into the device shaft was inflated at the level of the external cervical os to create a uterine seal. Negative pressure was created by attaching a self-contained, mobile, electrically powered, pressure-regulated vacuum pump with a sterile graduated canister. EXPERIENCE: In all 10 cases, the suction created an immediate seal at the cervical os, 50-250 mL of residual blood was evacuated from the uterine cavity, the uterus collapsed and regained tone within minutes, and hemorrhaging was controlled. The device remained in place for a minimum of 1 hour and up to 6.5 hours in one case while vaginal and perineal lacerations were easily repaired. CONCLUSION: This preliminary investigation suggests that a device designed to create vacuum-induced uterine tamponade may be a reasonable alternative to other devices used to treat atonic postpartum hemorrhage.
Authors: V Pingray; M Widmer; A Ciapponi; G J Hofmeyr; C Deneux; M Gülmezoglu; K Bloemenkamp; O T Oladapo; D Comandé; A Bardach; P Vázquez; G Cormick; F Althabe Journal: BJOG Date: 2021-07-19 Impact factor: 7.331
Authors: Chris-Henrik Wulfert; Christian Theodor Müller; Ahmed Farouk Abdel-Kawi; Wolfgang Schulze; Henning Schmidt-Seithe; Sonko Borstelmann; Gunnar Loske Journal: Innov Surg Sci Date: 2020-10-01
Authors: Mary E D'Alton; Kara M Rood; Marcela C Smid; Hyagriv N Simhan; Daniel W Skupski; Akila Subramaniam; Kelly S Gibson; Todd Rosen; Shannon M Clark; Donald Dudley; Sara N Iqbal; Michael J Paglia; Christina M Duzyj; Edward K Chien; Karen J Gibbins; Kathryn D Wine; Nana Ama A Bentum; Michelle A Kominiarek; Methodius G Tuuli; Dena Goffman Journal: Obstet Gynecol Date: 2020-11 Impact factor: 7.623
Authors: Joshua P Vogel; Alyce N Wilson; Nick Scott; Mariana Widmer; Fernando Althabe; Olufemi T Oladapo Journal: Int J Gynaecol Obstet Date: 2020-10-30 Impact factor: 3.561